Jasper Warrants from 2010 to 2025

JSPRW Stock  USD 0.14  0.02  16.67%   
Jasper Therapeutics Warrants yearly trend continues to be fairly stable with very little volatility. Warrants will likely drop to about 69 M in 2025. Warrants is securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company. View All Fundamentals
 
Warrants  
First Reported
2010-12-31
Previous Quarter
71.4 M
Current Value
69 M
Quarterly Volatility
8.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Jasper Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jasper Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.2 M, Selling General Administrative of 11.2 M or Other Operating Expenses of 40 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.99. Jasper financial statements analysis is a perfect complement when working with Jasper Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Jasper Therapeutics Correlation against competitors.
For more information on how to buy Jasper Stock please use our How to Invest in Jasper Therapeutics guide.

Latest Jasper Therapeutics' Warrants Growth Pattern

Below is the plot of the Warrants of Jasper Therapeutics over the last few years. It is securities that give the holder the right to purchase a company's stock at a specified price before a certain date. Warrants are similar to options but are typically issued directly by the company. Jasper Therapeutics' Warrants historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Jasper Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Warrants10 Years Trend
Slightly volatile
   Warrants   
       Timeline  

Jasper Warrants Regression Statistics

Arithmetic Mean86,791,992
Geometric Mean86,343,455
Coefficient Of Variation10.18
Mean Deviation7,862,847
Median93,082,270
Standard Deviation8,831,792
Sample Variance78T
Range24.1M
R-Value(0.86)
Mean Square Error22.1T
R-Squared0.74
Significance0.000021
Slope(1,591,431)
Total Sum of Squares1170T

Jasper Warrants History

202569 M
202471.4 M
202079.4 M

About Jasper Therapeutics Financial Statements

Jasper Therapeutics investors use historical fundamental indicators, such as Jasper Therapeutics' Warrants, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Jasper Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Warrants71.4 M69 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Jasper Stock Analysis

When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.